IDIBELL

FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

corporate_fareorganization

Web page: http://www.idibell.cat

Country: Spain

IDIBELL

- Funding / Projects
  (62)

62 Projects, page 1 of 13

DISCHROM (Chromatin diseases: from basic mechanisms to therapy)
assignment_turned_inProject2009 - 2013Partners:IDIBELL, UCL, UNIMORE, UOXF, Diagenode (Belgium) +5 partners
IDIBELL,
UCL,
UNIMORE,
UOXF,
Diagenode (Belgium),
CNR,
Alexander Fleming Biomedical Sciences Research Center,
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE,
AMU,
University of Insubria
Funder: European Commission Project Code: 238242
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
CURELUNG (Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis)
Open Access Mandate for Publications assignment_turned_inProject2011 - 2014Partners:UNITO, INT, KLINIKUM DER UNIVERSITAET ZU KOELN, UGA, FIMA +6 partners
UNITO,
INT,
KLINIKUM DER UNIVERSITAET ZU KOELN,
UGA,
FIMA,
Institut Gustave Roussy,
MRC,
MPG,
IDIBELL,
University of Liverpool,
BioVectis
Funder: European Commission Project Code: 258677
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
VESSEL (Vascular Endothelial interactionS and SpEciaLization)
assignment_turned_inProject2013 - 2016Partners:LAVISION BIOTEC GMBH, IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE, KI, University of Edinburgh, WWU +4 partners
LAVISION BIOTEC GMBH,
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE,
KI,
University of Edinburgh,
WWU,
IDIBELL,
UH,
FONDATION DU CENTRE PLURIDISCIPLINAIRE D'ONCOLOGIE,
NANOLOGICA AB
Funder: European Commission Project Code: 317250
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
MOAMAUX (Modulation of AMPA receptor properties by auxiliary subunits.)
assignment_turned_inProject2012 - 2015Partners:IDIBELL
IDIBELL
Funder: European Commission Project Code: 293498
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
IMMEEDIA (Immunomodulatory Effects of Exercise in Type 1 Diabetes)
assignment_turned_inProject2010 - 2014Partners:KI, UNIMI, FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR, San Raffaele Hospital, IDIBELL
KI,
UNIMI,
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR,
San Raffaele Hospital,
IDIBELL
Funder: European Commission Project Code: 247472
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

IDIBELL

IDIBELL

62 Projects, page 1 of 13

DISCHROM (Chromatin diseases: from basic mechanisms to therapy)

CURELUNG (Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis)

VESSEL (Vascular Endothelial interactionS and SpEciaLization)

MOAMAUX (Modulation of AMPA receptor properties by auxiliary subunits.)

IMMEEDIA (Immunomodulatory Effects of Exercise in Type 1 Diabetes)

Loading